These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8603814)

  • 1. Modulation of lymphokine-activated killer cell-mediated cytotoxicity by estradiol and tamoxifen.
    Baral E; Nagy E; Berczi I
    Int J Cancer; 1996 Apr; 66(2):214-8. PubMed ID: 8603814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol.
    Baral E; Nagy E; Berczi I
    Cancer; 1995 Jan; 75(2):591-9. PubMed ID: 7812928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target cells are sensitized for cytotoxic T-lymphocyte-mediated destruction by estradiol and tamoxifen.
    Baral E; Nagy E; Berczi I
    Int J Cancer; 1994 Jul; 58(1):64-8. PubMed ID: 8014017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-estrogens enhance the therapeutic effect of lymphokine-activated killer cells on the P815 murine mastocytoma.
    Baral E; Nagy E; Kangas L; Berczi I
    Int J Cancer; 1996 Aug; 67(4):580-5. PubMed ID: 8759619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination immunotherapy of the P815 murine mastocytoma with killer cells, IL-2 and anti-estrogens.
    Baral E; Nagy E; Kangas L; Berczi I
    Anticancer Res; 1997; 17(5A):3653-8. PubMed ID: 9413218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells.
    Baral E; Nagy E; Krepart GV; Lotocki RJ; Unruh HW; Berczi I
    Anticancer Res; 2000; 20(3B):2027-31. PubMed ID: 10928146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes.
    Nagy E; Baral E; Kangas L; Berczi I
    Anticancer Res; 1997; 17(2A):1083-8. PubMed ID: 9137453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms.
    Bean P; Mazumder A
    Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cells.
    Albertini MR; Gibson DF; Robinson SP; Howard SP; Tans KJ; Lindstrom MJ; Robinson RR; Tormey DC; Jordan VC; Sondel PM
    J Immunother (1991); 1992 Jan; 11(1):30-9. PubMed ID: 1734946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.
    Bean P; Agah R; Mazumder A
    J Biol Response Mod; 1990 Feb; 9(1):92-7. PubMed ID: 2181073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries.
    Aguilar R; Bellido C; Garrido-Gracia JC; Alonso R; Sánchez-Criado JE
    Reproduction; 2006 Apr; 131(4):763-9. PubMed ID: 16595727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
    Holladay FP; Heitz T; Wood GW
    J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.
    Lin TH; Chu TM
    Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Phytolacca acinosa polysaccharides I combined with interleukin-2 on the cytotoxicity of murine splenocytes against tumor cells.
    Wang HB; Chen WZ; Bao EJ; Zheng QY; Song HL; Fang J; Xu YX; Chen HS
    Yao Xue Xue Bao; 1995; 30(6):401-7. PubMed ID: 7572178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.